- Home
- EVCM vs ZLAB Comparison
EVCM vs ZLAB Comparison
Compare EVCM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVCM | ZLAB |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | China |
| Employees | 1800 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.4B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EVCM | ZLAB |
|---|---|---|
| Price | $10.10 | $18.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $10.67 | ★ $49.60 |
| AVG Volume (30 Days) | 92.7K | ★ 662.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.45 | 38.46 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $588,907,000.00 | $460,156,000.00 |
| Revenue This Year | $7.39 | $9.75 |
| Revenue Next Year | $5.84 | $26.03 |
| P/E Ratio | $250.25 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $7.66 | $15.96 |
| 52 Week High | $14.41 | $44.34 |
Technical Indicators
Market Signals| Indicator | EVCM | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 38.35 |
| Support Level | $9.35 | $18.29 |
| Resistance Level | $12.35 | $19.64 |
| Average True Range (ATR) | 0.81 | 0.99 |
| MACD | -0.18 | -0.28 |
| Stochastic Oscillator | 25.42 | 6.82 |
Price Performance
Historical ComparisonAbout EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.